Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer
oleh: M. Ruiz-Borrego, A. Chan, G. Marx, A. Brufsky, M. Trudeau, D. Egle, L. McCulloch, D. Tripathy, C.H. Barcenas
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2021-04-01 |
Deskripsi
No description available for this item.